American Journal of Epidemiology Vol. 131, No. 5: 781-793
Copyright © 1990 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
ATYPICAL METAPLASIA AND INCIDENCE OF BRONCHOGENIC CARCINOMA
1 Department of Epidemiology, School of Public Health, University of North Carolina Chapel Hill, NC
2 Department of Biostatistics, School of Public Health, University of North Carolina Chapel Hill, NC
Reprint requests to Dr. Marilyn F. Vine, Department of Epidemiology, School of Public Health, CB 7400, University of North Carolina, Chapel Hill, NC 21599-7400
The prognostic implication of atypical squamous metaplasia of the respiratory tract has been uncertain, especially for mild atypia. The relation between degree of severity of atypical metaplasia as detected by sputum cytology and incidence of bronchogenic carcinoma was assessed among 14,414 men aged 45 years or older who smoked one or more packs of cigarettes per day. Trial participants underwent sputum cytologic evaluations every 4 months for an average of 7.4 years as part of the Cooperative Early Lung Cancer Detection Program of the National Cancer Institute and were followed for the development of lung cancer between 1971 and 1983 at three institutions: The Johns Hopkins University, the Memorial Sloan-Kettering Cancer Center, and the Mayo Clinic. Analysis with logistic regression controlling for age, race, occupational exposures to lung carcinogens, average number of cytology records per year, and smoking habits revealed that the estimate of the relative rate (RR) of developing bronchogenic carcinoma was greater among men who had mild atypia as compared with men who had negative cytology readings, but there were marked differences among institutions (RR=1.1, 95% confidence interval (Cl) 0.8–1.5 at The Johns Hopkins University; PR=1.6, 95% Cl 1.1–2.5 at the Memorial Sloan-Kettering Cancer Center and PR=2.5, 95% Cl 1.6–4.0 at the Mayo Clinic). Results suggest that mild atypia as detected by cytologic evaluation of sputum is an indicator of a modest elevation in risk of bronchogenic carcinoma.
cytodiagnosis; cytology; lung neoplasms; metaplasia; sputum
3Present address: Center for Health Services Research in Primary Care, Department of Veterans Affairs Medical Center, Durham, NC.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. BOTA, J.-B. AULIAC, C. PARIS, J. METAYER, R. SESBOUE, G. NOUVET, and L. THIBERVILLE Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1688 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-C. Xu, J. S. Lee, J. J. Lee, R. C. Morice, X. Liu, S. M. Lippman, W. K. Hong, and R. Lotan Nuclear Retinoid Acid Receptor Beta in Bronchial Epithelium of Smokers Before and During Chemoprevention J Natl Cancer Inst, August 4, 1999; 91(15): 1317 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Clemens, R. A. Elyazeed, M. Rao, M. MPH, S. Savarino, B. Z. Morsy, Y. Kim, T. Wierzba, A. Naficy, and Y. J. Lee Early Initiation of Breastfeeding and the Risk of Infant Diarrhea in Rural Egypt Pediatrics, July 1, 1999; 104(1): 3e - 3. [Abstract] [Full Text]
|
|